Studies and perspectives of signal transduction in the skin

Experimental Dermatology

Volumn 1, Issue 5, 1992, Pages 207-220

  Inohara, Shinichi ^a  

^a HYOGO COLLEGE OF MEDICINE   (Japan)

Author keywords

phosphorylation; protein kinase C; protein tyrosine kinase; skin

Indexed keywords

7,12 DIMETHYLBENZ[A]ANTHRACENE; PHORBOL 13 ACETATE 12 MYRISTATE; PROTEIN KINASE C; PROTEIN TYROSINE KINASE;

ANIMAL; CELL COMMUNICATION; CYTOLOGY; HUMAN; IATROGENIC DISEASE; KERATINOCYTE; METABOLISM; REVIEW; SIGNAL TRANSDUCTION; SKIN; SKIN TUMOR;

9,10-DIMETHYL-1,2-BENZANTHRACENE; ANIMAL; CELL COMMUNICATION; HUMAN; KERATINOCYTES; PROTEIN KINASE C; PROTEIN-TYROSINE KINASE; SIGNAL TRANSDUCTION; SKIN; SKIN NEOPLASMS; TETRADECANOYLPHORBOL ACETATE;

EID: 0027106310     PISSN: 09066705     EISSN: 16000625     Source Type: Journal    
DOI: 10.1111/j.1600-0625.1992.tb00079.x     Document Type: Review

References (150)

1. Role of the cyclic AMP‐dependent protein kinase in signal transduction
2. 32P into phospholipids of pancreatic slices
3. Inositol phospholipids and cell surface receptor function
4. Calcium‐activated, phosholipid‐dependent protein kinase from rat brain, subcellular distribution, purification, and properties
5. The role of protein kinase C in cell surface signal transduction and tumor promotion
6. Inositol triphosphate, a novel second messeneer in cellular signal transduction
7. Direct activation of calcium‐activated, phospholipid‐dependent protein kinase by tumor‐promot ing phorbol ester
8. Studies and perspectives of protein kinase C
9. Inositol lipid and cell proliferation
10. Transforming gene product of rous sarcoma virus phosphorylates tyrosine
11. Protein‐tyrosine kinases
12. Identification of phosphotyrosine as a product of epidermal growth factor‐activated protein kinase in A‐431 cell membranes
13. Tumor promotion in epidermal cells in culture
14. Psoriasis as a possible defect of the adenyl cyclase‐cyclic AMP cascade
15. Cyclic AMP in relation to proliferation of the epidermal cell: a new view
16. Effects of cholera toxin on proliferation of cultured human keratinocytes in re lation to intracellular cyclic AMP levels
17. Epidermal cyclic AMP is not decreased in psoriatic lesions
18. Phosphorylation of epidermal keratin proteins by cyclic AMP‐dependent protein kinase
19. Phosphorylation of keratin polypeptides
20. Phosphorylation of pig epidermal soluble protein by endogeneous cAMP‐dependent protein kinase
21. Tumor promoter‐stimulated pro tein phosphorylation in mouse epidermis is inhibited by bromophenacyl bromide
22. Phosphorylation of soluble pig epidermal proteins by endogeneous calcium‐ activated, phospholipid‐dependent protein kinase
23. novel type of phorbol ester‐dependent protein phosphorylation in the particulate fraction of mouse epidermis
24. Regulation of creatinine phosphokinase B activity by protein kinase C
25. Protein kinase C and its substrates in tumor promoter‐sensitive and ‐resistant cells
26. Identification of hematoxylin‐stainable protein in epidermal keratohyalin granule as phosphorylated cystatin a by protein kinase C
27. Phorbol ester‐stimulated phosphorylation of keratinocyte transglutaminase in the membrane anchorage region
28. 2, as a substrate of protein kinase C in BALB/MK‐2 mouse keratinoeytes
29. Epidermal growth factor stimulates tyrosine phosphorylation of pig epidermal fibrous keratin
30. Calcium regulation of growth and differentiation of mouse epidermal cells in culture
31. Divergent responses in epidermal basal cells exposed to the tumor promoter 12‐O‐tetradecanoylphorbol‐l3‐acetate
32. Phorbol ester tumor promoters induce epidermal transglutaminase ac tivity
33. 2+ regulated epidermal cells
34. Similar effects of phospholipase C and phorbol ester tumor promoters on primary mouse epidermal cells
35. The biological significance of fatty acid turnover in keratinocyte proliferation and differentiation
36. Subcellular distribution of protein kinase c/phorbol ester receptors in differentiating mouse keratinocytes
37. Staurosporine induces protein kinase C agonist effects and maturation of normal and neoplastic mouse keratinocytes in vitro
38. Biphasic effects of 12‐O‐letradecanoylphorbol‐13‐acetate on the cell morphology of low calciumgrown human epidermal carcinoma cells: involvement of translocation and down regulation of protein kinase C
39. Application of phorbol ester to mouse skin causes a rapid and sustained loss of protein kinase C
40. Differential down‐regulation of epidermal protein kinase C by 12‐O‐tetradecanoylphorbol‐13‐acetate and diacylglycerol: association with epidermal hyperplasia and tumor promotion
41. Immunological demonstration of a calcium‐unresponsive protein kinase C of the δ‐type in different species and murine tissues, predominance in epidermis
42. Effects of protein kinase C activators on mouse skin in vivo
43. Diacylglycerols, unlike phorbol esters do not induce homologous desensitization or down‐regulation of protein kinase C in swiss 3T3 cells
44. Tumor promoter uncouples β‐adrenergie receptor from adenyl cyclase in mouse epidermis
45. Phorbol esters promote β‐adrenergic receptor phosphorylation and adenyl cyclase desensitization in duck erythrocytes
46. Early prostaglandin E synthesis is an obligatory event in the induction of cell proliferation in mouse epidermis in vivo by the phorbol ester TPA
47. 2α, levels in mouse epidermis are increased by tumor‐promoting phorbol esters
48. 2α, in the epidermis of psoriasis
49. Leukotrienes and other lipoxygenase products in pathogenesis and therapy of psoriasis and other dermatoses
50. Induction of polyamine‐biosynthetic enzymes in mouse epidermis by tumor‐promoting agents
51. Ornithine decarbox‐ ylase activity, cell proliferation, and tumor promotion in mouse epidermis in vivn
52. Glucocorticoid inhibits elev ated polyamine biosynthesis in psoriasis
53. Phorbol ester tumor promoters induce epidermal transglutaminase ac tivity
54. Mem brane associated transglutaminase activity is increased in psoriatic versus normal epidermis
55. Differen tial retinoic acid inhibition of ornithine decarboxylase induction by 12‐O‐tetradecanoyl‐phorbol‐l3‐acelale and germicidal ultraviolet light
56. Cyclosporin A inhibits biological effects of tumor promoting phorbol esters
57. 3, of epidermal ornithine decar boxylase caused by 12‐O‐ietradecanoyl‐phorbol‐13‐acetate and teleocidin B
58. Decreased protein kinase C activity in psoriatic versus normal epidermis
59. Immunohistological identification of protein kinase C isozymes in normal and psoriatic epidermis
60. A monoclonal antibody recognising the site of limited proteolysis of protein kinase C
61. The family of protein kinase C for signal transduction
62. Protein tyrosine kinase and protein phosphotyrosine phosphatase in normal and psoriatic skin
63. 125]epidermal growth factor binding and receptor distri bution in psoriasis
64. Overexpression of transforming growth factor a in psoriatic epidermis
65. Induction of trans forming growth factor‐a expression in human keratinocytes by phorbol ester
66. Signal transduction in normal and psoriatic epidermis
67. Cyclosporin A inhibits protein kinase C activity: a contributing mechanism in the development of nephro‐ toxicity
68. Cyclosporin A inhibitis protcolytic cleavage and degradation of mem brane‐bound protein kinase C in hepatocytes after stim ulation by phorbol ester
69. NF‐KB: a pleiotropic mediator of inducible and tissue‐specific gene control
70. Activation in vitro of NF‐kB by phosphorylation of its inhibitor 1KB
71. The inhibition of EGF‐dependent proliferation of keratinocytes by tyrophostin tyrosine kinase blocker
72. Tyrosine phosphorylation is an early and specific event involved in primary keratinocyte differentiation
73. Endotheln, vasopressin, and angiotensin II enhance tyrosine phos phorylation by protein kinase C‐dependent and ‐independent pathways in glomerular mesanginl cells
74. Stimulation of B‐cells via the membrane immunoglobulin receptor or with phorbol myristate 13‐acetate induces tyrosine phosphorylation and activation of a 42‐KDa microtuble‐associated protein‐2 kinase
75. Molecular themes in ontogenesis
76. et al. Oncogenes and signal transduction
77. Communication between protein lyrosine and protein serine/threonine phosphorylation
78. MAP kinase by any other name smells just as sweet
79. Protein kinases and protooncogcnes: biochemical regulators of the eukaryotic cell cycle
80. The cdc25 M‐phase inducer: an unconventional protein phosphatase
81. Increase of the catalytic activity of phospholipase C‐γ I by tyrosine phos phorylation
82. Modulation of epider mal growth factor receptors in psoriatic lesions during treatment with topical EGF
83. Growth arrest induced by transforming growth factor pi is accompanied by protein phosphatase activation in human keratinocytes
84. An unidentified virus which causes the rapid production of tumours in mice
85. Morphologic responses to a murine crythroblastosis virus
86. Trans forming genes of carcinomas and neuroblastomas intro duced into mouse fibroblasls
87. Mouse skin carcinomas induced in vivo by chemical carcinogens have a transforming Harveyras oncogene
88. ras GENES
89. Expression of p21ras in normal and malignant human tissues: lack of association with proliferation and malignancy
90. Oncogene activation in human benign tumors of the skin (keratoacanthomas): is HRAS involved in differentiation as well as proliferation
91. Association of EGF receptor expression with proliferating cells and 112 of ras p2l expression with differentiating cells in various skin tumors
92. Signal transduction through small GTPases – A tale of two GAPs
93. PDGF β‐preceptor stimulates tyrosine phos‐ phorylation of GAP and association of GAP with a sig naling complex
94. Carcinogen‐induced mutation in the mouse c‐Ha‐ras gene provide evidence of multiple pathways for tumor progression
95. The role of protein kinase C in growth control and the concept of carcinogenesis as a progressive disorder in signal transduction
96. Okadaic acid: an additional non‐phorbol‐12‐letradecanoate‐13‐acctate‐type tumor promoter
97. Okadaic acid: a new probe for the study of cellular regulation
98. Altered protein kinase C activity in biopsies of human colonic adenomas and carcinomas
99. Cooperation between oncogenes
100. Vinculin phosphorylation by the, src kinase
101. Pastan I. Vinculin: a cytoskeletal substrate of protein kinase C
102. Association of type 3 protein kinase C with focal contacts in rat embryo fibroblasts
103. Specific proto‐oncogenic tyrosine kin‐ ases of src family are enriched in cell‐to‐cell adherens junctions where the level of tyrosine phosphorylation is elevated
104. Calciumin duced assembly of adherens junctions in keratinocytcs
105. Activation of protein kinase C results in the displacement of its myriosloylated, alanine‐rich substrate from punetates in macrophage filopodia
106. Regulation by phosphorylation of reversible association of a myrisloylated protein kinase C substrate with the plasma mem brane
107. MARCKS is an actin filament crosslinking protein regulated by protein kinase C and calcium‐calmodlulin
108. Involvement of protein kinase C in translocation of desmoplakin from cytosol to plasma membrane during desmosome formation in human squamous cell carcinoma cells grown in low to normal calcium concentration
109. Actin filament and desmosome formation in cultured human keratinocytes
110. Immunohisto‐chemical localization of desmosomal and cytoskeletal proteins in the epidermis of healthy individuals and patients with Hailey‐Hailey's disease
111. Selective proliferation of normal human melanocytes in vitro in the presence of phorbol ester and cholera toxin
112. Basic fibroblast growth factor from human keratinocytes is a natural mitogen for melanocytes
113. Human melanocyte growth and differentiation: a decade of new data
114. Human melanogenesis is stimulated by diacylglycerol
115. Ultraviolet stimulated melanogenesis by human melanocytes is augmented by diacylglycerol but not TPA
116. Protein kinase C down regulation, and not transient activation, correlates with melanocyte growth
117. Aberrant melanogenesis and melanocytic tumor development in trans‐genic mice that carry a metallothionein/ret fusion gene
118. Suppressor cell activation and enhanced skin allograft survival after tumor promoter but not initiator induced depletion of cutaneous Langerhans cells
119. Further evidence for the self‐reproducing capacity of Langerhans cells in human skin
120. Expression of protein kinase C isozyme in epidermal Langerhans cells of the mouse
121. Expression of protein kinase C isozyme in human Langerhans' cells
122. Effects of epidermal growth factor on hair growth in the mouse
123. Human hair growth in vitro
124. Distribution and number of epidermal growth factor receptors in rat tissues during embryonic development, hair formation, and the adult hair growth cycle
125. Comparison of epidermal growth factor binding and receptor distribution in normal human epidermis and epidermal appandages
126. Regulation mechanisms of hair growth
127. Detection of ornithine decarboxylase gene expression in 12‐O‐tetradecanoyl‐phorbol‐13‐acetale‐treated mouse skin using in situ hybridization
128. Hyperactivity of fibroblasts cultured from psoriatic skin, I. Faster proliferation and effect of serum withdrawal
129. Mitogenic effects of sera from normal and psoriatic subjects on human fibroblasts
130. Deficiency of cyclic AMP‐dependent protein kinase in human psoriasis
131. Increased protein kinase C activity in fibroblast membranes from psoriatic patients
132. Protein kinase C activity in normal and psoriatic cells: cultures of fibroblasts and lymphocytes
133. Isolation and growth of endothelial cells from the microvessels of the newborn human foreskin in cell culture
134. Microvascular endothelial cell culture
135. Mechanisms of angiogenesis in normal and diseased skin
136. Human dermal microvascular endothelial cells in vitro: effects of cyclic AMP on cellular morphology and proliferation rate
137. Cyclic adenosine monophosphate levels and the function of skin microvas‐ cular endothelial cells
138. The cellular functios of small GTP‐binding proteins
139. Purification and characterization of a novel GTP‐binding protein with a molecular weight of 24, 000 from bovine brain membranes
140. Nucleotide and deduced amino acid sequences of a GTP‐binding protein family with molecular weight of 25, 000 from bovine brain
141. Tissue distribution of smg p25A, a ras p21‐like GTP‐binding protein, studied by use of a specific monoclonal antibody
142. Immunohistological localization of smg p25A, a ras p21‐like guanosine 5′‐ triphosphate (GTP)‐binding protein in human skin
143. Flow cytometric analysis of protein kinase C in lymph node cells during the induction phase of contact hypersensitivity reaction
144. Protein kinase C: a target for anti‐inflammatory therapy
145. The protein kinase family: conserved features and deduced phylogeny of the catalytic domains
146. A phorbol ester receptor/protein kinase C, nPKCn, a new member of the protein kinase C family predominantly expressed in lung and skin
147. Protein kinase C mRNA levels and activity in reconstituted normal human epidermis: relationships to cell differentiation